Access the full text.
Sign up today, get DeepDyve free for 14 days.
Stephen Smith, Yongyue Zhang, M. Jenkinson, Jacqueline Chen, P. Matthews, A. Federico, N. Stefano (2002)
Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change AnalysisNeuroImage, 17
Makoto Yamamoto, L. Cui, K. Johkura, K. Asanuma, Y. Okouchi, N. Ogiwara, K. Sasaki (2006)
Branching ducts similar to mesonephric ducts or ureteric buds in teratomas originating from mouse embryonic stem cells.American journal of physiology. Renal physiology, 290 1
J. Mohal, H. Tailor, W. Khan (2012)
Sources of adult mesenchymal stem cells and their applicability for musculoskeletal applications.Current stem cell research & therapy, 7 2
J. Bresser, Marileen Portegies, A. Leemans, G. Biessels, L. Kappelle, M. Viergever (2011)
A comparison of MR based segmentation methods for measuring brain atrophy progressionNeuroImage, 54
G. Ren, Juanjuan Su, Liying Zhang, Xin Zhao, Weifang Ling, Andrew L'huillie, Jimin Zhang, Yongqing Lu, A. Roberts, W. Ji, Huatang Zhang, A. Rabson, Yufang Shi (2009)
Species Variation in the Mechanisms of Mesenchymal Stem Cell‐Mediated ImmunosuppressionSTEM CELLS, 27
A. Bhasin, M. Srivastava, S. Mohanty, R. Bhatia, S. Kumaran, S. Bose (2013)
Stem cell therapy: A clinical trial of strokeClinical Neurology and Neurosurgery, 115
F. Durand-Dubief, B. Belaroussi, J. Armspach, M. Dufour, S. Roggerone, S. Vukusic, Salem Hannoun, D. Sappey-Marinier, C. Confavreux, F. Cotton (2012)
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification TechniquesAmerican Journal of Neuroradiology, 33
Oh Bang, Jin Lee, Phil Lee, Gwang Lee (2005)
Autologous mesenchymal stem cell transplantation in stroke patientsAnnals of Neurology, 57
O. Adeoye, R. Hornung, P. Khatri, D. Kleindorfer (2011)
Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States: A Doubling of Treatment Rates Over the Course of 5 YearsStroke, 42
X. Bao, M. Feng, Junji Wei, Q. Han, Hao Zhao, Gui-lin Li, Zhaohui Zhu, Haiqun Xing, Y. An, Chuan Qin, R. Zhao, Renzhi Wang (2011)
Transplantation of Flk‐1+ human bone marrow‐derived mesenchymal stem cells promotes angiogenesis and neurogenesis after cerebral ischemia in ratsEuropean Journal of Neuroscience, 34
M. François, R. Romieu-Mourez, S. Stock-Martineau, M. Boivin, J. Bramson, J. Galipeau (2009)
Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.Blood, 114 13
J. Tatarishvili, Koichi Oki, Emanuela Monni, P. Koch, Tamar Memanishvili, A. Buga, Vivek Verma, A. Popa-Wagner, O. Brüstle, O. Lindvall, Z. Kokaia (2014)
Human induced pluripotent stem cells improve recovery in stroke-injured aged rats.Restorative neurology and neuroscience, 32 4
G. Turc, P. Aguettaz, Nelly Ponchelle-Dequatre, H. Hénon, O. Naggara, X. Leclerc, C. Cordonnier, D. Leys, J. Mas, C. Oppenheim (2014)
External Validation of the MRI-DRAGON Score: Early Prediction of Stroke Outcome after Intravenous ThrombolysisPLoS ONE, 9
T. Burns, G. Steinberg (2011)
Stem cells and stroke: opportunities, challenges and strategiesExpert Opinion on Biological Therapy, 11
A. Yoo, Z. Chaudhry, R. Nogueira, M. Lev, P. Schaefer, L. Schwamm, Joshua Hirsch, R. Gonzalez (2012)
Infarct Volume Is a Pivotal Biomarker After Intra-Arterial Stroke TherapyStroke, 43
S. Johnston, S. Mendis, C. Mathers (2009)
Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modellingThe Lancet Neurology, 8
Seiichiro Inoue, F. Popp, G. Koehl, P. Piso, H. Schlitt, E. Geissler, M. Dahlke (2006)
Immunomodulatory Effects of Mesenchymal Stem Cells in a Rat Organ Transplant ModelTransplantation, 81
Y. Ikegame (2013)
Among mesenchymal stem cells: for the best therapy after ischemic strokeStem Cell Research & Therapy, 4
O. Honmou, K. Houkin, T. Matsunaga, Y. Niitsu, S. Ishiai, Rie Onodera, S. Waxman, J. Kocsis (2011)
Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.Brain : a journal of neurology, 134 Pt 6
Xinfeng Liu, Ruidong Ye, T. Yan, H. Ford, S. Yu, Gelin Xu, Xin-ying Fan, Yongjun Jiang, Xinfeng Liua, Ruidong Yea, Tao Yanb, Shan Yud, Ling Weid, Gelin Xua, Xin-he Fana, Yongjun Jianga, R. Stetlere, George Liuf, Jieli Chenb (2014)
Cell based therapies for ischemic stroke: From basic science to bedsideProgress in Neurobiology, 115
Stephen Smith, N. Stefano, M. Jenkinson, P. Matthews (2001)
Normalized Accurate Measurement of Longitudinal Brain ChangeJournal of Computer Assisted Tomography, 25
W. Hall (1998)
The safety and efficacy of stereotactic biopsy for intracranial lesionsCancer, 82
É. Mezey, K. Chandross, G. Harta, Richard Maki, S. Mckercher (2000)
Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow.Science, 290 5497
A. Aldahmash, M. Atteya, Mona Elsafadi, M. Al-Nbaheen, Husain Al-Mubarak, Radhakrishnan Vishnubalaji, A. Alroalle, Suzan Al-Harbi, Muthurangan Manikandan, K. Matthaei, Amer Mahmood (2013)
Teratoma formation in immunocompetent mice after syngeneic and allogeneic implantation of germline capable mouse embryonic stem cells.Asian Pacific journal of cancer prevention : APJCP, 14 10
Jiamei Li, Hua Zhu, Y. Liu, Qin Li, Shan Lu, M. Feng, Yanfeng Xu, Lan Huang, Chun-mei Ma, Y. An, R. Zhao, Renzhi Wang, Chuan Qin (2010)
Human mesenchymal stem cell transplantation protects against cerebral ischemic injury and upregulates interleukin-10 expression in Macaca fascicularisBrain Research, 1334
L. Hao, Z. Zou, Hong-xiao Tian, Yubo Zhang, Huchuan Zhou, Lei Liu (2014)
Stem Cell-Based Therapies for Ischemic StrokeBioMed Research International, 2014
K. Hong, L. Ali, S. Selco, G. Fonarow, J. Saver (2011)
Weighting Components of Composite End Points in Clinical Trials: An Approach Using Disability-Adjusted Life-YearsStroke, 42
J. Lee, J. Hong, Gyeong Moon, Phil Lee, Y. Ahn, O. Bang (2010)
A Long‐Term Follow‐Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic StrokeSTEM CELLS, 28
S. Ma, N. Xie, Wenzhao Li, B. Yuan, Yufang Shi, Ying Wang (2013)
Immunobiology of mesenchymal stem cellsCell Death and Differentiation, 21
M. Friedrich, M. Martins, Mariana Araújo, Charles Klamt, L. Vedolin, B. Garicochea, E. Raupp, Jeber Ammar, D. Machado, J. Costa, R. Nogueira, P. Rosado-de-Castro, R. Mendez-Otero, G. Freitas (2012)
Intra-Arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Patients with Moderate to Severe Middle Cerebral Artery Acute Ischemic StrokeCell Transplantation, 21
D. Phinney, D. Prockop (2007)
Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current ViewsSTEM CELLS, 25
D. Tornero, S. Wattananit, Marita Madsen, P. Koch, J. Wood, J. Tatarishvili, Y. Mine, Ruimin Ge, Emanuela Monni, K. Devaraju, R. Hevner, O. Brüstle, O. Lindvall, Z. Kokaia (2013)
Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery.Brain : a journal of neurology, 136 Pt 12
Mark Eckert, Q. Vu, Kate Xie, Jingxia Yu, Wenbin Liao, S. Cramer, Weian Zhao (2013)
Evidence for High Translational Potential of Mesenchymal Stromal Cell Therapy to Improve Recovery from Ischemic StrokeJournal of Cerebral Blood Flow & Metabolism, 33
V. Roger, A. Go, D. Lloyd‐Jones, E. Benjamin, J. Berry, W. Borden, D. Bravata, S. Dai, E. Ford, C. Fox, H. Fullerton, C. Gillespie, S. Hailpern, J. Heit, V. Howard, B. Kissela, S. Kittner, D. Lackland, J. Lichtman, L. Lisabeth, D. Makuc, G. Marcus, A. Marelli, D. Matchar, C. Moy, D. Mozaffarian, M. Mussolino, G. Nichol, N. Paynter, E. Soliman, P. Sorlie, N. Sotoodehnia, T. Turan, S. Virani, N. Wong, D. Woo, M. Turner (2012)
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.Circulation, 125 1
Loren Glover, N. Tajiri, Nathan Weinbren, H. Ishikawa, K. Shinozuka, Y. Kaneko, D. Watterson, C. Borlongan (2011)
A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem CellsTranslational Stroke Research, 3
BACKGROUND AND PURPOSE: Mesenchymal stem cells have potential as a regenerative therapy in ischemic stroke. We sought to determine MR imaging findings after mesenchymal stem cell implantation in chronic middle cerebral artery infarcts and to compare brain volume changes in patients with mesenchymal stem cells with those in age-matched healthy controls and controls with chronic stable MCA infarcts. MATERIALS AND METHODS: We retrospectively identified 5 patients receiving surgical mesenchymal stem cell implantation to an MCA infarct from January 1, 2005, to July 1, 2013, with MR imaging immediately and 1 year postimplantation. Images at both time points were evaluated for any postimplantation complications. Structural image evaluation using normalization of atrophy software was used to determine volume changes between time points and compare them with those in healthy and age- and sex-matched controls with chronic, stable MCA infarcts by using Kruskal-Wallis and Mann-Whitney U tests. RESULTS: Susceptibility signal loss and enhancement at the implantation site were seen. No teratoma, tumor, or heterotopia was identified. Volumetric analysis showed a trend toward less overall volume loss after mesenchymal stem cell implantation (0.736; 95% CI, −4.15–5.62) compared with that in age- and sex-matched controls with chronic, stable MCA infarcts (−3.59; 95% CI, −12.3 to −5.21; P = .09), with a significantly greater growth-to-loss ratio in infarcted regions (1.30 and 0.78, respectively, P = .02). A trend toward correlation of growth-to-loss ratio with improvement in physical examination findings was seen ( r = 0.856, P = .06). CONCLUSIONS: Postoperative changes consistent with stereotactic implantation were seen, but no teratoma, tumor, or heterotopia was identified. Initial findings suggest a trend toward less volume loss after mesenchymal stem cell implantation compared with that in age- and sex-matched controls with chronic, stable MCA infarcts, with a significantly greater growth-to-loss ratio in the infarcted tissue. ABBREVIATIONS: %BVC percentage brain volume change GLR growth-to-loss ratio MCAI controls age- and sex-matched controls with chronic, stable MCA infarcts MSC mesenchymal stem cells SIENA structural image evaluation using normalization of atrophy ST section thickness
American Journal of Neuroradiology – American Journal of Neuroradiology
Published: Jun 1, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.